Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care

Table 2 Association between anticancer treatment given last 30 days of life and adverse events contributing to death

Variables	AE contributing to death	OR	95% CI	P value
Treatment last 30 days^a	32.9%	2.26	1.211–4.216	0.01
No treatment last 30 days	17.8%
Treatment last 30 days^b		1.85	1.014–3.359	0.045
Age		0.97	0.938–0.995	0.021
Length of stay		0.98	0.984–0.962	0.184
Gender		1.84	0.935–3.623	0.047
Type cancer				0.145
Gastrointestinal		0.98	0.370–2.599	0.968
Respiratory		0.68	0.181–2.516	0.559
Breast and gynaecology		0.37	0.130–1.027	0.056
Urinary		0.35	0.132–0.934	0.036
Haematological		0.75	0.244–2.280	0.607
Others

Binary logistic regression analyses presenting ^aunadjusted and ^badjusted results

ISSN: 1472-684X